Physician profile
Thaddeus E Szarzanowicz
NPI 1972515740
$19,391.21
in general payments reported to CMS, 2019-2025
26 companies · $336 in 2025
The $336 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,162 · 2020: $1,563 · 2021: $3,234 · 2022: $2,344 · 2023: $3,296 · 2024: $3,457 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,234 · Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,233.66 |
| Food and Beverage | $1,854.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,527.71 | 2019-2024 | |
| Prodigy Surgical Distribution, INC. | $4,193.21 | 2019-2025 | |
| Depuy Synthes Sales INC. | $1,840.84 | 2020-2024 | Inhance, Monovisc, Orthovisc |
| Smith+Nephew, INC. | $325.53 | 2019-2024 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Ferring Pharmaceuticals INC. | $277.44 | 2019-2025 | Euflexxa |
| Amgen INC. | $275.06 | 2022-2025 | Evenity, Krystexxa, Prolia |
| Pacira Therapeutics, INC. | $162.67 | 2019-2021 | |
| Medical Device Business Services, INC. | $149.63 | 2023 | Attune, Inhance |
| Abbott Laboratories | $123.98 | 2021-2025 | Axium, Proclaim |
| Bioventus LLC | $95.59 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $58.58 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Heraeus Medical, LLC. | $50.40 | 2019-2022 | |
| Horizon Therapeutics Plc | $46.12 | 2019-2022 | |
| Misonix INC | $31.93 | 2021 | |
| Innovation Technologies INC | $28.95 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $22.72 | 2021 | |
| Abbvie INC. | $20.51 | 2025 | |
| Orthofix Medical, INC. | $20.23 | 2021 | |
| Ethicon US, LLC | $19.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.53 | 2022 | |
| Kci USA, INC. | $19.49 | 2022 | |
| Pfizer INC. | $17.99 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.68 | 2022 | |
| Djo, LLC | $16.31 | 2022 | |
| Becton, Dickinson and Company | $15.44 | 2022 | |
| Arthrosurface Incorporated | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thaddeus Szarzanowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.